S. Hayashi and J. C. Hogg, Adenovirus infections and lung disease, Curr Opin Pharmacol, vol.7, pp.237-243, 2007.

S. Herold, C. Becker, K. M. Ridge, and G. R. Budinger, Influenza virusinduced lung injury: pathogenesis and implications for treatment, Eur Respir J, vol.45, pp.1463-1478, 2015.

M. Eisenhut, Extrapulmonary manifestations of severe respiratory syncytial virus infection -a systematic review, Crit Care, vol.10, p.107, 2006.

S. Morichi, H. Kawashima, H. Ioi, G. Yamanaka, Y. Kashiwagi et al., Classification of acute encephalopathy in respiratory syncytial virus infection, J Infect Chemother, vol.17, pp.776-781, 2011.

D. L. Webster, A. H. Gardner, T. J. Dye, and R. S. Chima, Status epilepticus: a possible association with human metapneumovirus infection, Pediatrics, vol.133, pp.747-750, 2014.

A. Goenka, B. D. Michael, E. Ledger, I. J. Hart, M. Absoud et al., Neurological manifestations of influenza infection in children and adults: results of a national British surveillance study, Clin Infect Dis, vol.58, pp.775-784, 2014.

T. Niizuma, A. Okumura, K. Kinoshita, and T. Shimizu, Acute encephalopathy associated with human metapneumovirus infection, Jpn J Infect Dis, vol.67, pp.213-215, 2014.

S. Toovey, Influenza-associated central nervous system dysfunction: a literature review, Travel Med Infect Dis, vol.6, pp.114-124, 2008.

K. Bohmwald, J. A. Espinoza, P. A. Gonzalez, S. M. Bueno, and C. A. Riedel, Kalergis AM: Central nervous system alterations caused by infection with the human respiratory syncytial virus, Rev Med Virol, vol.24, pp.407-419, 2014.

, In this review is discussed recent findings linking the neurological, extrapulmonary effects of hRSV with infection and functional impairment of the CNS

Y. C. Huang, S. L. Huang, S. P. Chen, Y. L. Huang, C. G. Huang et al., Adenovirus infection associated with central nervous system dysfunction in children, J Clin Virol, vol.57, pp.300-304, 2013.

M. Goritzka, L. R. Durant, C. Pereira, S. Salek-ardakani, P. J. Openshaw et al., Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection, J Virol, vol.88, pp.6128-6136, 2014.

R. K. Durbin, S. V. Kotenko, and J. E. Durbin, Interferon induction and function at the mucosal surface, Immunol Rev, vol.255, pp.25-39, 2013.

C. E. Samuel, Antiviral actions of interferons, Clin Microbiol Rev, vol.14, pp.778-809, 2001.

N. Marr, T. I. Wang, S. H. Kam, Y. S. Hu, A. A. Sharma et al., Attenuation of respiratory syncytial virus-induced and rig-i-dependent type i ifn responses in human neonates and very young children, J Immunol, vol.192, pp.948-957, 2014.

S. H. Lai, S. L. Liao, K. S. Wong, and T. Y. Lin, Defective innate immune responses to respiratory syncytial virus infection in ovalbumin-sensitized mice, J Microbiol Immunol Infect, 2014.

C. Selvaggi, A. Pierangeli, M. Fabiani, L. Spano, A. Nicolai et al., Interferon lambda 1-3 expression in infants hospitalized for rsv or hrv associated bronchiolitis, J Infect, vol.68, pp.467-477, 2014.

, The authors present evidence of differences in the IFN lambda 1-3 levels in infants hospitalized for respiratory syncytial virus (RSV) or rhinovirus (HRV) bronchiolitis

C. Sommereyns, S. Paul, P. Staeheli, and T. Michiels, Ifn-lambda (ifn-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo, PLoS Pathog, vol.4, p.1000017, 2008.

J. Segovia, A. Sabbah, V. Mgbemena, S. Y. Tsai, T. H. Chang et al., Tlr2/myd88/nfkappab pathway, reactive oxygen species, potassium efflux activates nlrp3/asc inflammasome during respiratory syncytial virus infection, PLoS One, vol.7, p.29695, 2012.

K. Triantafilou, S. Kar, E. Vakakis, S. Kotecha, and M. Triantafilou, Human respiratory syncytial virus viroporin sh: a viral recognition pathway used by the host to signal inflammasome activation, Thorax, vol.68, pp.66-75, 2013.

R. S. Gomez, I. Guisle-marsollier, K. Bohmwald, S. M. Bueno, and A. M. Kalergis, Respiratory syncytial virus: pathology, therapeutic drugs and prophylaxis, Immunol Lett, vol.162, pp.237-247, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02162213

D. E. De-almeida-nagata, T. Demoor, C. Ptaschinski, H. A. Ting, S. Jang et al., Il-27r-mediated regulation of il-17 controls the development of respiratory syncytial virus-associated pathogenesis, Am J Pathol, vol.184, pp.1807-1818, 2014.

S. L. Lambert, S. Aslam, E. Stillman, M. Macphail, C. Nelson et al., A novel respiratory syncytial virus (RSV) f subunit vaccine adjuvanted with gla-se elicits robust protective th1-type humoral and cellular immunity in rodent models, PLoS One, vol.10, p.119509, 2015.

U. Schauer, S. Hoffjan, T. Rothoeft, H. Bartz, S. Konig et al., Severe respiratory syncytial virus infections and reduced interferon-gamma generation in vitro, Clin Exp Immunol, vol.138, pp.102-109, 2004.

T. E. Faber, H. Groen, M. Welfing, K. J. Jansen, and L. J. Bont, Specific increase in local il-17 production during recovery from primary rsv bronchiolitis, J Med Virol, vol.84, pp.1084-1088, 2012.

S. L. Gaffen, Structure and signalling in the il-17 receptor family, Nat Rev Immunol, vol.9, pp.556-567, 2009.

A. J. Stoppelenburg, S. De-roock, M. P. Hennus, L. Bont, and M. Boes, Elevated th17 response in infants undergoing respiratory viral infection, Am J Pathol, vol.184, pp.1274-1279, 2014.

, The authors show that Th17 cells are absent in healthy newborns, Th17 cells are present in peripheral blood and the airways of infants that experience viral infection

S. Mukherjee, D. M. Lindell, A. A. Berlin, S. B. Morris, T. P. Shanley et al., Il-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease, Am J Pathol, vol.179, pp.248-258, 2011.

M. T. Lotz and R. S. Peebles, Mechanisms of respiratory syncytial virus modulation of airway immune responses, Curr Allergy Asthma Rep, vol.12, pp.380-387, 2012.

M. M. Monick, L. S. Powers, I. Hassan, D. Groskreutz, T. O. Yarovinsky et al., Respiratory syncytial virus synergizes with th2 cytokines to induce optimal levels of tarc/ccl17, J Immunol, vol.179, pp.1648-1658, 2007.

L. I. Tapia, S. Ampuero, M. A. Palomino, V. Luchsinger, N. Aguilar et al., Respiratory syncytial virus infection and recurrent wheezing in Chilean infants: a genetic background, Infect Genet Evol, vol.16, pp.54-61, 2013.

, This study shows that IL-4/IL-13 pathway is involved in RSV infection conditions. Authors evaluated by a candidate-gene approach, whether genetic polymorphisms in IL-4/IL-13 pathway are associated with RSV infection severity and its outcome in Chilean children

E. M. Castilow, D. K. Meyerholz, and S. M. Varga, Il-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease, J Immunol, vol.180, pp.2376-2384, 2008.

B. Puthothu, M. Krueger, J. Forster, and A. Heinzmann, Association between severe respiratory syncytial virus infection and il13/il4 haplotypes, J Infect Dis, vol.193, pp.438-441, 2006.

H. Kawashima, Y. Kashiwagi, H. Ioi, S. Morichi, S. Oana et al., Production of chemokines in respiratory syncytial virus infection with central nervous system manifestations, J Infect Chemother, vol.18, pp.827-831, 2012.

, this study the roles of cytokines in the CSF was evaluated suggest that chemokines in CSF play roles in neurological complications in RSVinfected children

J. A. Espinoza, K. Bohmwald, P. F. Cespedes, R. S. Gomez, S. A. Riquelme et al.,